Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LET gel vs EMLA and lidocaine for pediatric laceration repair
NCT04378283Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- May 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine + epinephrine + tetracaine in laceration, sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Pain during skin repair at 2 weeks. Started May 2016; status: completed.
02
Drugs
lidocaine + epinephrine + tetracaine
03
Conditions
laceration
Beyond the preview
Go deeper on NCT04378283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378283.